| |
| |
|
| Insider
Information: |
Patel Snehal |
| Relationship: |
CEO and CFO, Director,... |
| City: |
Stafford |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
5,350,777 |
|
|
Indirect Shares
|
2,712,886 |
|
|
| Direct
Value |
$77,318,728 |
|
|
|
Indirect Value
|
$39,201,203 |
|
|
| Total
Shares |
8,063,663 |
|
|
| Total
Value |
$116,519,930 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Greenwich Lifesciences, Inc. |
GLSI |
CEO and CFO, Director,... |
2024-04-01 |
5,350,777 |
2022-06-24 |
2,712,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-04-01 |
4 |
B |
$19.08 |
$57,240 |
D/D |
3,000 |
5,350,777 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-22 |
4 |
B |
$19.98 |
$49,950 |
D/D |
2,500 |
5,347,777 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-20 |
4 |
B |
$17.68 |
$26,520 |
D/D |
1,500 |
5,345,277 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-05 |
4/A |
B |
$12.49 |
$43,715 |
D/D |
3,500 |
5,343,777 |
3.23 |
- |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-05 |
4 |
B |
$12.49 |
$380,945 |
D/D |
30,500 |
5,343,777 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-03-04 |
4 |
B |
$13.03 |
$53,423 |
D/D |
4,100 |
5,340,277 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-02-16 |
4 |
B |
$11.16 |
$120,528 |
D/D |
10,800 |
5,336,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2024-02-15 |
4 |
B |
$11.07 |
$140,589 |
D/D |
12,700 |
5,325,377 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-11-10 |
4 |
B |
$10.17 |
$50,838 |
D/D |
5,000 |
5,312,677 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-11-03 |
4 |
B |
$9.11 |
$31,885 |
D/D |
3,500 |
5,307,677 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-10-26 |
4 |
B |
$7.97 |
$19,925 |
D/D |
2,500 |
5,304,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-10-25 |
4 |
B |
$7.91 |
$19,775 |
D/D |
2,500 |
5,301,677 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-10-10 |
4 |
B |
$9.07 |
$9,070 |
D/D |
1,000 |
5,299,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-10-04 |
4 |
B |
$8.63 |
$17,260 |
D/D |
2,000 |
5,298,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-09-19 |
4 |
B |
$8.95 |
$35,800 |
D/D |
4,000 |
5,296,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-09-11 |
4 |
B |
$9.48 |
$9,480 |
D/D |
1,000 |
5,292,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-08-22 |
4 |
B |
$9.97 |
$9,970 |
D/D |
1,000 |
5,291,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-08-04 |
4 |
B |
$10.55 |
$21,100 |
D/D |
2,000 |
5,290,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-07-21 |
4 |
B |
$9.20 |
$9,200 |
D/D |
1,000 |
5,288,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-05-17 |
4 |
B |
$11.69 |
$11,690 |
D/D |
1,000 |
5,287,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-19 |
4 |
B |
$11.10 |
$77,700 |
D/D |
7,000 |
5,286,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-18 |
4 |
B |
$11.12 |
$22,240 |
D/D |
2,000 |
5,279,177 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-04-11 |
4 |
B |
$12.42 |
$62,100 |
D/D |
5,000 |
5,271,177 |
3.23 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-03-10 |
4 |
B |
$12.12 |
$12,120 |
D/D |
1,000 |
2,737,486 |
3.15 |
% |
|
| GLSI |
Greenwich Lifesciences, I... |
CEO and CFO |
• • • |
2023-02-17 |
4 |
B |
$16.53 |
$9,918 |
D/D |
600 |
2,736,486 |
3.15 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
